ConductScience.org, home

Paper78051

Immunoproliferation and cancer: a common macrophage-derived promoter substance.

Salmon SE and 1 other. Lancet, 1978. Cited by 71 papers, by iCite.

Cite this record

ConductScience Library. Immunoproliferation and cancer: a common macrophage-derived promoter substance. Papers, record 78051. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/78051

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Immunoproliferation and cancer: a common macrophage-derived promoter substance.
PubMed
Journal
Lancet
PubMed
Year
1978
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
71
iCite
Relative citation ratio, by iCite
2.3
iCite
Revised in PubMed
2019-06-10
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Salmon SES E
2Hamburger AWA W

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antibody-Producing CellsMajor topic
B-LymphocytesMajor topic
Growth SubstancesMajor topic
MacrophagesMajor topic
NeoplasmsMajor topic
Animals
Cell Division
Clone Cells
Epidermal Growth Factor
Humans
In Vitro Techniques
Mice
Models, Biological
Neoplasm Metastasis

Source PubMed

Download CSV of topics

Cited by16

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 71 citations.

PMIDTitleJournalYearIn PapersSource
29375123The chemokine MCP-1 (CCL2) in the host interaction with cancer: a foe or ally?Cell Mol Immunol2018https://conductscience.org/library/papers/29375123PubMed
7426298Effect of host-cell interactions on clonogenic carcinoma cells in human malignant effusions.Br J Cancer1980https://conductscience.org/library/papers/7426298PubMed
7295507Promotion of fibrosarcoma cell growth by products of syngeneic host macrophages.Br J Cancer1981https://conductscience.org/library/papers/7295507PubMed
7250325Changes in immune reactivity during growth of an adenovirus 12-induced transplantable tumour in CBA mice.Experientia1981https://conductscience.org/library/papers/7250325PubMed
7238796A simple procedure for removal of intra- and extra-tumoral macrophages from primary tumor cultures.Experientia1981https://conductscience.org/library/papers/7238796PubMed
6789682I. Tumor growth in mice with depressed capacity to mount inflammatory responses: possible role of macrophages.Am J Pathol1981https://conductscience.org/library/papers/6789682PubMed
6764378Macrophages and neoplasms: new insights and their implication in tumor immunobiology.Cancer Metastasis Rev1982https://conductscience.org/library/papers/6764378PubMed
6699074The pattern of the mononuclear infiltrate as a prognostic parameter in flat superficial spreading melanomas.J Cancer Res Clin Oncol1984https://conductscience.org/library/papers/6699074PubMed
6500600Enhancement of rat ACT-1 tumor clonogenicity by xenogeneic mouse macrophages.In Vitro1984https://conductscience.org/library/papers/6500600PubMed
6332671Inhibition of lymphocyte mitogenesis by factor(s) released from macrophages isolated from ascitic fluid of advanced ovarian cancer patients.Cancer Immunol Immunother1984https://conductscience.org/library/papers/6332671PubMed
3664532Infiltration of primary and metastatic melanomas with macrophages of the 25F9-positive phenotype.Cancer Immunol Immunother1987https://conductscience.org/library/papers/3664532PubMed
3464353Immunoregulating activity of tumor-associated macrophages.Cancer Immunol Immunother1986https://conductscience.org/library/papers/3464353PubMed
3057504Human granulocyte-macrophage colony-stimulating factor is a growth factor active on a variety of cell types of nonhemopoietic origin.Proc Natl Acad Sci U S A1988https://conductscience.org/library/papers/3057504PubMed
1280562Prediction of response to drug therapy of cancer. A review of in vitro assays.Drugs1992https://conductscience.org/library/papers/1280562PubMed
455581Vindesine. A clinical trial with special reference to neurological side effects.Cancer Chemother Pharmacol1979https://conductscience.org/library/papers/455581PubMed
314909Peritoneal macrophages from adjuvant arthritic rats enhance tumour cell growth in vitro.Experientia1979https://conductscience.org/library/papers/314909PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
CSF31440PubTator's text mininghttps://conductscience.org/library/genes/1440

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/78051

GET https://conductscience.org/api/papers/v1/78051/authors